Stephen Willey
Stock Analyst at Stifel
(3.91)
# 647
Out of 5,124 analysts
126
Total ratings
43.01%
Success rate
13.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Buy | $30 → $40 | $26.33 | +51.92% | 7 | Nov 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $68 → $115 | $99.74 | +15.30% | 2 | Nov 13, 2025 | |
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $1.85 | +494.59% | 5 | Nov 11, 2025 | |
| IRON Disc Medicine | Reinstates: Buy | $125 | $79.41 | +57.41% | 1 | Nov 3, 2025 | |
| ACLX Arcellx | Reinstates: Buy | $129 | $65.20 | +97.85% | 1 | Oct 16, 2025 | |
| INCY Incyte | Maintains: Buy | $110 → $115 | $98.77 | +16.43% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $4.00 | +125.00% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $174.04 | -16.69% | 8 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $3.42 | +104.68% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $43.83 | -6.46% | 19 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $11.86 | +136.09% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.61 | +210.56% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $5.47 | +265.76% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $18.97 | +84.50% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $13.08 | +664.53% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.32 | +203.03% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $16.83 | +179.26% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.31 | +1,209.76% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.53 | +161.44% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $44.82 | +38.33% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.37 | +67.60% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.85 | +548.65% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.74 | +16,451.72% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.33 | +801.29% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.15 | +247.83% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $397.65 | -69.07% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $79.11 | -40.59% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $59.43 | +83.41% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $19.99 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $9.22 | +149.46% | 5 | Feb 7, 2018 |
Zymeworks
Nov 19, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $26.33
Upside: +51.92%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $68 → $115
Current: $99.74
Upside: +15.30%
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $1.85
Upside: +494.59%
Disc Medicine
Nov 3, 2025
Reinstates: Buy
Price Target: $125
Current: $79.41
Upside: +57.41%
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $65.20
Upside: +97.85%
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $98.77
Upside: +16.43%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $4.00
Upside: +125.00%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $174.04
Upside: -16.69%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.42
Upside: +104.68%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $43.83
Upside: -6.46%
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $11.86
Upside: +136.09%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.61
Upside: +210.56%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.47
Upside: +265.76%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $18.97
Upside: +84.50%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $13.08
Upside: +664.53%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.32
Upside: +203.03%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $16.83
Upside: +179.26%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.31
Upside: +1,209.76%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.53
Upside: +161.44%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $44.82
Upside: +38.33%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $5.37
Upside: +67.60%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.85
Upside: +548.65%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.74
Upside: +16,451.72%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.33
Upside: +801.29%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.15
Upside: +247.83%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $397.65
Upside: -69.07%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $79.11
Upside: -40.59%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $59.43
Upside: +83.41%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $19.99
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $9.22
Upside: +149.46%